Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells

Biochemical and Biophysical Research Communications

Volumn 323, Issue 2, 2004, Pages 660-667

  Liu, Wei Jun ^a   Zhang, Yong Wei ^a   Shen, Ying ^a   Jiang, Jian Fei ^a   Miao, Ze Hong ^a   Ding, Jian ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

A549 cells; Antineoplastic agents; Salvicine; Telomerase; Telomere

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; MITOMYCIN C; OKADAIC ACID; SALVICINE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; TELOMERE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NAPHTHOQUINONES; TELOMERASE; TELOMERE; TREATMENT OUTCOME;

EID: 4544272521     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.08.135     Document Type: Article

References (20)

1. F.O. Odago, and S.L. Gerson Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy Trends Pharmacol. Sci. 24 2003 328 331
2. G. Saretzki Telomerase inhibition as cancer therapy Cancer Lett. 194 2003 209 219
3. Y.S. Cong, W.E. Wright, and J.W. Shay Human telomerase and its regulation Microbiol. Mol. Biol. Rev. 66 2002 407 425
4. A.M. Burger, J.A. Double, and D.R. Newell Inhibition of telomerase activity by cisplatin in human testicular cancer cells Eur. J. Cancer 33 1997 638 644
5. N. Sato, K. Mizumoto, M. Kusumoto, S. Nishio, N. Maehara, T. Urashima, T. Ogawa, and M. Tanaka Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide Br. J. Cancer 82 2000 1819 1826
6. M. Akiyama, J. Horiguchi-Yamada, S. Saito, Y. Hoshi, O. Yamada, H. Mizoguchi, and H. Yamada Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro Eur. J. Cancer 35 1999 309 315
7. W.C. Ku, A.J. Cheng, and T.C. Wang Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture Biochem. Biophys. Res. Commun. 241 1997 730 736
8. L.H. Meng, X.X. He, J.S. Zhang, and J. Ding DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae Acta Pharmacol. Sin. 21 2001 741 746
9. L.H. Meng, J.S. Zhang, and J. Ding Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzymeâ€"DNA cleavage complexes Biochem. Pharmacol. 62 2001 733 741
10. J.S. Zhang, J. Ding, Q. Tang, M. Li, M. Zhao, L.J. Lu, L.J. Chen, and S.T. Yuan Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs Bioorg. Med. Chem. Lett. 9 1999 2731 2736
11. C. Qing, J.S. Zhang, and J. Ding In vitro cytotoxicity of salvicine, a novel diterpenoid quinone Acta Pharm. Sin. 20 1999 297 302
12. Z.H. Miao, T. Tang, Y.X. Zhang, J.S. Zhang, and J. Ding Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells Int. J. Cancer 106 2003 108 115
13. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.H. Shoemaker, and M.R. Boyd Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay Cancer Res. 48 1988 589 601
14. G.A. Ulaner, J.F. Hu, T.H. Vu, H. Oruganti, L.C. Giudice, and A.R. Hoffman Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium Int. J. Cancer 85 2000 330 335
15. W. Klapper, W. Qian, C. Schulte, and R. Parwaresch DNA damage transiently increases TRF2 mRNA expression and telomerase activity Leukocyte 17 2003 2007 2015
16. I. Faraoni, M. Turriziani, G. Masci, L. De Vecchis, J.W. Shay, E. Bonmassar, and G. Graziani Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro Clin. Cancer Res. 3 1997 579 585
17. I. Faraoni, G. Graziani, M. Turriziani, G. Masci, M. Mezzetti, A. Testori, U. Veronesi, and E. Bonmassar Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples Lab. Invest. 79 1999 993 1005
18. T.R. Cressey, M.J. Tilby, and D.R. Newell Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines Eur. J. Cancer 38 2002 586 593
19. M. Folini, C. De Marco, L. Orlandi, M.G. Daidone, and N. Zaffaroni Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents Eur. J. Cancer 36 2000 2137 2145
20. W.J. Liu, J.F. Jiang, D. Xiao, and J. Ding Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis Biochem Pharmacol. 64 2002 1677 1687